Best Researcher Award
| George Konstantakopoulos |
| Researcher |
George Konstantakopoulos |
| Affiliation |
National and Kapodistrian University of Athens |
| Country |
Greece |
| Scopus ID |
16425957400 |
| Documents |
90 |
| Citations |
1644 |
| h-index |
23 |
| Subject Area |
Medicine and Health Sciences |
| Event |
Environmental Scientists |
| ORCID |
0000-0002-5206-4263 |
George Konstantakopoulos
National and Kapodistrian University of Athens, Greece
George Konstantakopoulos is a researcher affiliated with the National and Kapodistrian University of Athens whose scholarly activities focus on medicine and health sciences. His publication record, citation performance, and sustained academic engagement reflect meaningful contributions to clinical research and interdisciplinary scientific development.[1]
Abstract
George Konstantakopoulos has established a consistent academic profile through peer-reviewed publications and collaborative medical research. His work demonstrates sustained contributions to healthcare knowledge and interdisciplinary scientific advancement.[2]
Keywords
Medicine, Health Sciences, Clinical Research, Psychiatry, Medical Education, Scientific Publications, Evidence-Based Medicine, Academic Research.
Introduction
Modern medical research relies on rigorous scientific investigation and international collaboration to improve patient outcomes. Researchers with sustained publication activity contribute significantly to the advancement of evidence-based healthcare.[3]
Research Profile
With 90 indexed publications, 1,644 citations, and an h-index of 23, George Konstantakopoulos has developed a recognized research profile. His scholarly work reflects continuous academic productivity and international scientific visibility.[1]
Research Contributions
His publications contribute to the understanding of clinical medicine, mental health, and healthcare practice through evidence-based investigations. These studies support scientific discussion and encourage continued interdisciplinary collaboration.[4]
Publications
His research has appeared in internationally indexed journals and conference publications, reflecting consistent scholarly dissemination. The publication record illustrates ongoing engagement with contemporary medical research topics.[5]
Research Impact
Citation metrics indicate that his work has been referenced by researchers across multiple disciplines. Such impact demonstrates academic relevance and continued influence within the international scientific community.[1]
Award Suitability
Based on his publication productivity, citation record, and sustained research engagement, George Konstantakopoulos demonstrates qualifications consistent with consideration for the Best Researcher Award. His academic achievements align with the objectives of recognizing excellence in scientific research.
Conclusion
George Konstantakopoulos has established a respected scholarly profile through sustained publication activity and measurable research impact. His academic record represents continued commitment to advancing medicine and health sciences.[1]
External Links
References
-
- Elsevier. (n.d.). Scopus Author Details: George Konstantakopoulos, Author ID 16425957400.
https://www.scopus.com/pages/authors/16425957400
- ORCID. (n.d.). George Konstantakopoulos Research Profile.
https://orcid.org/0000-0002-5206-4263
- Konstantakopoulos, G., Gonidakis, F., Georgantopoulos, G., Stefanatou, P., & Fotopoulou, A. (2026). Metacognitive confidence independently predicts body image delusionality in anorexia and bulimia nervosa. Journal of Psychiatric Research. Advance online publication.
- Tsionis, A., Fragkaki, A.-M., Ioannidi, N., Argyropoulos, D., Stefanatou, P., Kravariti, E., & Konstantakopoulos, G. (2025). A new look at functioning in euthymic bipolar disorder: The role of theory of mind and residual symptoms. Psychiatry Research. Advance online publication.
https://pubmed.ncbi.nlm.nih.gov/41045720/
- Konstantakopoulos, G., Argyropoulos, D., & Tsionis, A. (2025). The preclinical discovery and development of gepirone hydrochloride extended-release tablets: The first oral selective 5-HT1A receptor agonist for the treatment of major depressive disorder. Expert Opinion on Drug Discovery. Advance online publication.
https://www.tandfonline.com/doi/full/10.1080/17460441.2025.2552144